These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1510 related items for PubMed ID: 33744777

  • 1. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
    Zhang J, Wang C, Wang H, Li X, Xu J, Yu K.
    Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
    [Abstract] [Full Text] [Related]

  • 2. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1.
    Luo YP, Jiang L, Kang K, Fei DS, Meng XL, Nan CC, Pan SH, Zhao MR, Zhao MY.
    Int Immunopharmacol; 2014 May; 20(1):24-32. PubMed ID: 24583148
    [Abstract] [Full Text] [Related]

  • 3. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.
    Li D, Li C, Wang T, Zhang C, Zhu Z, Zhang G, Fang B.
    Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204
    [Abstract] [Full Text] [Related]

  • 4. Cyclic helix B peptide alleviates sepsis-induced acute lung injury by downregulating NLRP3 inflammasome activation in alveolar macrophages.
    Zhang XP, Zhang WT, Qiu Y, Ju MJ, Yang C, Tu GW, Luo Z.
    Int Immunopharmacol; 2020 Nov; 88():106849. PubMed ID: 32795894
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
    Yang JW, Mao B, Tao RJ, Fan LC, Lu HW, Ge BX, Xu JF.
    J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
    [Abstract] [Full Text] [Related]

  • 6. Suppression of NOD-like receptor protein 3 inflammasome activation and macrophage M1 polarization by hederagenin contributes to attenuation of sepsis-induced acute lung injury in rats.
    Wang L, Zhao M.
    Bioengineered; 2022 Mar; 13(3):7262-7276. PubMed ID: 35266443
    [Abstract] [Full Text] [Related]

  • 7. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L, Fei D, Gong R, Yang W, Yu W, Pan S, Zhao M, Zhao M.
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [Abstract] [Full Text] [Related]

  • 8. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
    Li J, Ma J, Li M, Tao J, Chen J, Yao C, Yao S.
    Life Sci; 2021 Apr 15; 271():119192. PubMed ID: 33577850
    [Abstract] [Full Text] [Related]

  • 9. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
    Liu X, Jin X, Yu D, Liu G.
    Int Immunopharmacol; 2019 Nov 15; 76():105886. PubMed ID: 31520990
    [Abstract] [Full Text] [Related]

  • 10. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
    Liu Y, Zhang Y, You G, Zheng D, He Z, Guo W, Antonina K, Shukhrat Z, Ding B, Zan J, Zhang Z.
    Inflamm Res; 2024 Jan 15; 73(1):47-63. PubMed ID: 38147126
    [Abstract] [Full Text] [Related]

  • 11. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y, Li H, Liu S, Pan P, Su X, Tan H, Wu D, Zhang L, Song C, Dai M, Li Q, Mao Z, Long Y, Hu Y, Hu C.
    Mol Immunol; 2018 Jul 15; 99():134-144. PubMed ID: 29783158
    [Abstract] [Full Text] [Related]

  • 12. Apocynin alleviates lung injury by suppressing NLRP3 inflammasome activation and NF-κB signaling in acute pancreatitis.
    Jin HZ, Yang XJ, Zhao KL, Mei FC, Zhou Y, You YD, Wang WX.
    Int Immunopharmacol; 2019 Oct 15; 75():105821. PubMed ID: 31437787
    [Abstract] [Full Text] [Related]

  • 13. Knockdown of angiopoietin-like 4 suppresses sepsis-induced acute lung injury by blocking the NF-κB pathway activation and hindering macrophage M1 polarization and pyroptosis.
    Sun B, Bai L, Li Q, Sun Y, Li M, Wang J, Shi X, Zhao M.
    Toxicol In Vitro; 2024 Feb 15; 94():105709. PubMed ID: 37820748
    [Abstract] [Full Text] [Related]

  • 14. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
    Dong L, Zhu YH, Liu DX, Li J, Zhao PC, Zhong YP, Chen YQ, Xu W, Zhu ZQ.
    J Immunol Res; 2019 Feb 15; 2019():7264383. PubMed ID: 30937316
    [Abstract] [Full Text] [Related]

  • 15. Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.
    Wang YC, Liu QX, Zheng Q, Liu T, Xu XE, Liu XH, Gao W, Bai XJ, Li ZF.
    Inflammation; 2019 Aug 15; 42(4):1301-1310. PubMed ID: 30887396
    [Abstract] [Full Text] [Related]

  • 16. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice.
    Wang WT, Zhang YY, Li ZR, Li JM, Deng HS, Li YY, Yang HY, Lau CC, Yao YJ, Pan HD, Liu L, Xie Y, Zhou H.
    Phytomedicine; 2024 Jul 15; 129():155591. PubMed ID: 38692075
    [Abstract] [Full Text] [Related]

  • 17. Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation.
    Qin W, Tong X, Liang R, Tang K, Wu X, Jia Y, Tan N.
    J Ethnopharmacol; 2021 May 10; 271():113827. PubMed ID: 33460751
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of combination of anakinra and MCC950 against acute lung injury is achieved through suppression of the NF-κB-mediated-MAPK and NLRP3-caspase pathways.
    Wang X, Chen S, Zhao L, Shi X.
    Int Immunopharmacol; 2021 Aug 10; 97():107506. PubMed ID: 34022766
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S, Yu Z, Yuan T, Wang L, Wang X, Yang H, Sun L, Wang Y, Du G.
    Int Immunopharmacol; 2016 Nov 10; 40():219-228. PubMed ID: 27620503
    [Abstract] [Full Text] [Related]

  • 20. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
    Shan M, Wan H, Ran L, Ye J, Xie W, Lu J, Hu X, Deng S, Zhang W, Chen M, Wang F, Guo Z.
    Drug Des Devel Ther; 2024 Nov 10; 18():1369-1384. PubMed ID: 38681210
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 76.